The Québec Consortium for Drug Discovery (CQDM) is a precompetitive research consortium driven by the mission is to fund the development of breakthrough tools and technologies that enhance biopharmaceutical R&D productivity and accelerate the development of safer and more effective drugs. CQDM is also the catalyst where academia, governments, the pharmaceutical industry and the biotechnology converge to create practical solutions to complex medical challenges.
Our vision is to become a global leader actively involved in creating Canadian and International networks dedicated to advancing next-generation technologies to accelerate drug discovery and bring better cures to patients.
|For whom ?||Researchers and companies|
|How much ?||Depending on the program, up to $ 1.5M|
|What ?||Investment Fund|
|For what ?||Innovative projects that meet unmet medical needs|